MARKET

MYOK

MYOK

MyoKardia
NASDAQ

Real-time Quotes | Nasdaq Last Sale

68.93
-0.03
-0.04%
Opening 11:51 01/27 EST
OPEN
67.74
PREV CLOSE
68.96
HIGH
69.39
LOW
66.26
VOLUME
147.55K
TURNOVER
--
52 WEEK HIGH
78.28
52 WEEK LOW
39.01
MARKET CAP
3.19B
P/E (TTM)
-13.2128
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MYOK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MYOK News

  • Wells Fargo Maintains Overweight on MyoKardia, Raises Price Target to $96
  • Benzinga.01/17 14:59
  • The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
  • Benzinga.01/16 12:22
  • The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
  • Benzinga.01/15 13:22
  • MyoKardia down 5% on stock sales deal
  • seekingalpha.01/06 20:41

More

Industry

Biotechnology & Medical Research
-1.03%
Pharmaceuticals & Medical Research
-0.52%

Hot Stocks

Name
Price
%Change

About MYOK

MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company is engaged in the business of developing and commercializing therapeutics. The Company has used its precision medicine platform to generate an initial pipeline of over four therapeutic programs for the chronic treatment of two forms of heritable cardiomyopathy-hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM). Additionally, the Company has three preclinical programs, HCM-2, DCM-2 and LUS-1. Its lead product candidate, MYK-461, is an orally-administered small molecule designed to reduce excessive cardiac muscle contractility leading to HCM.
More

Webull offers Myokardia Inc (MYOK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.